XML 39 R17.htm IDEA: XBRL DOCUMENT
v3.25.1

Share-Based Compensation | 12 Months Ended
--- | ---
Mar. 29, 2025
Share-Based Compensation [Abstract] |
Share-Based Compensation | Note 10 – Share-based Compensation We maintain a long-term incentive plan whereby eligible employees and non-employee directors may be granted non-qualified service condition stock options, non-qualified market condition stock options, restricted stock awards, and restricted stock units. We grant share-based awards to continue to attract and retain employees and to better align employees’ interests with those of our shareholders. Monro issues new shares of Common Stock upon the exercise of stock options. Share-based compensation expense included in cost of sales and OSG&A expense in Monro’s Consolidated Statements of Income and Comprehensive Income for 2025, 2024, and 2023 was $4.7 million, $4.3 million, and $5.7 million, respectively, and the related income tax benefit for each year was $1.2 million, $1.1 million, and $1.4 million, respectively. Monro currently grants stock option awards, shares of restricted stock and restricted stock units under the 2007 Incentive Stock Option Plan (the “2007 Plan”), as amended and restated effective August 2017. At March 29, 2025, there were a total of 5,001,620 shares and 460,404 shares that were authorized and available for grant under the 2007 Plan, respectively. Non-Qualified Stock Options Generally, employee options vest over a four-year period, and have a duration of six years. Outstanding options are exercisable for various periods through May 2030.
Stock Option Activity |  |  |  |  |  |  | Weighted average |  |  | Aggregate
|  | Stock |  |  | Weighted average |  | Remaining Contractual |  |  | Intrinsic
|  | Options |  |  | Exercise Price |  | Term (years) |  |  | Value (a)
Outstanding as of March 30, 2024 |  | 417,910 |  | $ | 52.44 |  |  |  |  |
Granted |  | 193,769 |  |  | 26.91 |  |  |  |  |
Exercised |  | — |  |  | — |  |  |  |  |
Canceled |  | (112,276) |  |  | 48.27 |  |  |  |  |
Outstanding as of March 29, 2025 |  | 499,403 |  | $ | 43.48 |  | 4.07 |  | $ | —
Vested and exercisable as of March 29, 2025 |  | 303,337 |  | $ | 49.33 |  | 3.63 |  | $ | —
(a)Total shares valued at the market price of the underlying stock as of March 29, 2025, less the exercise price. As of March 29, 2025, the total unrecognized compensation expense related to unvested stock option awards was $1.1 million, which is expected to be recognized over a weighted average period of approximately two years. The weighted average grant date fair value of options granted during 2025, 2024, and 2023 was $6.60, $11.02, and $12.73, respectively. The total fair value of stock options vested during 2025, 2024, and 2023 was $1.7 million, $1.4 million, and $1.7 million, respectively.
Stock Option Exercises |  |  |  |  |  |  |  |
(millions) |  | 2025 |  |  | 2024 |  |  | 2023
Total intrinsic value of stock options exercised | $ | 0.0 |  | $ | 0.0 |  | $ | 0.1
Cash received for exercise price |  | 0.0 |  |  | 0.0 |  |  | 0.7
Income tax benefit |  | — |  |  | — |  |  | —
Restricted Stock Monro issues restricted stock and restricted stock units to certain members of management as well as non-employee directors of the Company. Restricted stock units represent shares issued upon vesting in the future whereas restricted stock awards represent shares issued upon grant that are restricted. The fair value for restricted stock units and restricted stock awards is calculated based on the stock price on the date of grant. Restricted stock units do not have voting rights but earn dividends during the vesting period. The recipients of the restricted stock awards have voting rights and earn dividends during the vesting period. The dividends are paid to the recipient at the time the restricted stock or restricted stock unit becomes vested. If the recipient leaves Monro prior to the vesting date for any reason, the shares of restricted stock, or the shares underlying the restricted stock unit, and the dividends accrued on those shares will be forfeited and returned to Monro. The restricted stock units and awards vest equally over three years or four years. During 2022, the Company granted 40,000 restricted stock units in connection with the appointment of its new President and Chief Executive Officer effective April 5, 2021. 20,000 restricted stock units are time vesting. 20,000 restricted stock units would have vested upon the Company’s common stock price meeting certain market conditions between April 2021 and December 2023. These shares did not vest because the stock price market conditions were not achieved by December 31, 2023. In 2024 and 2023, the Company issued a limited number of performance based restricted stock units to members of senior management which may vest at the end of three years upon the attainment of minimum thresholds of return on invested capital. In 2025, the Company issued a limited number of performance based restricted stock units to members of senior management which may vest at the end of three years upon the attainment of minimum thresholds of the relative total shareholder return.
Non-vested Restricted Stock Activity |  |  |  |  | Weighted average
|  |  |  |  | Grant-date
|  | Restricted Shares |  |  | Fair Value per Share
Outstanding as of March 30, 2024 |  | 259,894 |  | $ | 43.43
Granted |  | 264,049 |  |  | 25.65
Vested |  | (75,910) |  |  | 39.80
Forfeited |  | (69,132) |  |  | 40.90
Outstanding as of March 29, 2025 |  | 378,901 |  | $ | 32.22
As of March 29, 2025, the total unrecognized compensation expense related to unvested restricted shares was $5.9 million, which is expected to be recognized over a weighted average period of approximately two years. The weighted average grant date fair value of restricted shares granted during 2025, 2024, and 2023 was $25.65, $37.09, and $46.43, respectively. The total fair value of restricted shares vested during 2025, 2024, and 2023 was $3.0 million, $3.7 million, and $2.8 million, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration